Cell Reports · 2024 · 12 citations · 38 references
Life SciencesMolecular BiologyOncologyCell SignalingGene ExpressionSignal TransductionCancer Cell SignalingInnate Immune Signaling PathwaysInterferon ResponsesProtein Kinase CascadesRna InterferenceSignal Transduction In CancerDouble-stranded Rna SensingDouble-stranded Rna VirusesDouble-stranded Viral RnaExoribonuclease FunctionInhibition Of Interferon ResponsesInterferon-stimulated GenesRescueType Ii Interferon Signaling
Emerging data suggest that induction of viral mimicry responses through activation of double-stranded RNA (dsRNA) sensors in cancer cells is a promising therapeutic strategy. One approach to induce viral mimicry is to target molecular regulators of dsRNA sensing pathways. Here, we show that the exoribonuclease XRN1 is a negative regulator of the dsRNA sensor protein kinase R (PKR) in cancer cells with high interferon-stimulated gene expression. XRN1 deletion causes PKR pathway activation and consequent cancer cell lethality. Disruption of interferon signaling with the JAK1/2 inhibitor ruxolitinib can decrease cellular PKR levels and rescue sensitivity to XRN1 deletion. Conversely, interferon-β stimulation can increase PKR levels and induce sensitivity to XRN1 inactivation. Lastly, XRN1 deletion causes accumulation of endogenous complementary sense/anti-sense RNAs, which may represent candidate PKR ligands. Our data demonstrate how XRN1 regulates PKR and how this interaction creates a vulnerability in cancer cells with an activated interferon cell state.
38
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina, Giordano Caponigro, Nicolas Stransky et al. · Nature · 2012 · 8.5K citations
Medicine, Oncology, Pharmacology +15
Defining a Cancer Dependency Map
Aviad Tsherniak, Francisca Vázquez, Phil Montgomery et al. · Cell · 2017 · 3.5K citations · Full text